![Jason Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason Wang
Corporate Officer/Principal bij Changzhou Kanghui Medical Innovation Co. Ltd.
Actieve functies van Jason Wang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Changzhou Kanghui Medical Innovation Co. Ltd.
![]() Changzhou Kanghui Medical Innovation Co. Ltd. Medical SpecialtiesHealth Technology Changzhou Kanghui Medical Innovation Co., Ltd. is one of China's leading orthopedic companies, with products in the segments of Trauma, Spine, and Joint Implants & Instruments. With a history of high quality manufacturing and strong domestic sales and marketing capabilities, Kanghui has attracted strong institutional investor support from top tier venture capital companies, including IDG VC Partners, TDF, SIG, CDH and Vivo Ventures. KangHui is differentiated from its domestic competitors by its international orientation on product quality and innovation. They spend significantly on R & D to improve their products with a focus on maintaining market leadership in their product segments. Likewise, their quality control team (trained in manufacturing techniques and processes at Komatsu) has helped the company reach international standards in quality. Their collaborations with multi-national orthopedic companies, including Depuy (J&J), Smith & Nephew, Biomet, Stryker and Paragon, are a testament to the quality standards they set for the company. | Corporate Officer/Principal | - | - |
Loopbaan van Jason Wang
Statistieken
Internationaal
China | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Changzhou Kanghui Medical Innovation Co. Ltd.
![]() Changzhou Kanghui Medical Innovation Co. Ltd. Medical SpecialtiesHealth Technology Changzhou Kanghui Medical Innovation Co., Ltd. is one of China's leading orthopedic companies, with products in the segments of Trauma, Spine, and Joint Implants & Instruments. With a history of high quality manufacturing and strong domestic sales and marketing capabilities, Kanghui has attracted strong institutional investor support from top tier venture capital companies, including IDG VC Partners, TDF, SIG, CDH and Vivo Ventures. KangHui is differentiated from its domestic competitors by its international orientation on product quality and innovation. They spend significantly on R & D to improve their products with a focus on maintaining market leadership in their product segments. Likewise, their quality control team (trained in manufacturing techniques and processes at Komatsu) has helped the company reach international standards in quality. Their collaborations with multi-national orthopedic companies, including Depuy (J&J), Smith & Nephew, Biomet, Stryker and Paragon, are a testament to the quality standards they set for the company. | Health Technology |
- Beurs
- Insiders
- Jason Wang
- Ervaring